By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

FibroGen, Inc. 

225 Gateway Boulevard

South San Francisco  California  94080  U.S.A.
Phone: 650-866-7200 Fax: 650-866-7202


SEARCH JOBS


Industry
Biotechnology






Company News
FibroGen, Inc. (FGEN) Announces Second Quarter 2015 Financial Results 8/14/2015 9:54:18 AM
FibroGen, Inc. (FGEN) Release: Nephrology Dialysis Transplantation Reports Phase II Data Of Investigational Orally Active HIF-PHI Roxadustat (FG-4592) Shows Improved Hemoglobin Levels In Non-Dialysis CKD Subjects With Anemia 8/13/2015 7:43:47 AM
FibroGen, Inc. (FGEN) To Report Second Quarter 2015 Financial Results On August 13, 2015 8/10/2015 10:20:58 AM
FibroGen, Inc. (FGEN) Appoints Jeffrey W. Henderson To Board Of Directors 8/7/2015 11:16:24 AM
FibroGen, Inc. (FGEN) Receives FDA Clearance to Proceed With Clinical Study of FG-3019 in Duchenne Muscular Dystrophy 7/28/2015 7:05:31 AM
FibroGen, Inc. (FGEN) Announces Receipt Of $120 Million License Payment From AstraZeneca PLC (AZN) 6/30/2015 7:20:56 AM
FibroGen, Inc. (FGEN) To Webcast Presentation At The Goldman, Sachs & Co. Global Healthcare Conference 6/1/2015 5:03:45 PM
FibroGen, Inc. (FGEN) Announces First Quarter 2015 Financial Results 5/12/2015 11:24:34 AM
FibroGen, Inc. (FGEN) Announces Receipt Of Milestone Payment From AstraZeneca PLC (AZN) For Successful Completion Of Long-Term Pre-Clinical Safety Studies Of Roxadustat 5/7/2015 10:17:40 AM
FibroGen, Inc. (FGEN) Announces 2014 Financial Results And Provides Corporate Update 3/27/2015 9:42:33 AM
123456789
//-->